• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [20330 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Stapled transanal rectal resection for obstructed defecation syndrome
2014     NIHR Health Technology Assessment programme START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
2017     NIHR Health Technology Assessment programme Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services
2017     NIHR Health Technology Assessment programme Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services
2007     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) State of knowledge on the Coughassist (TM) (from Emerson), a mechanical system for clearance of bronchial secretions
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) State of Knowledge on the eFlow rapid (from PARI), an electronic nebuliser
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) State of Knowledge on the The VestTM (from Hill-Rom), a mechanical system for mucociliary clearance of the airway
2003     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) State of the art on double-electrode medullary electrostimulation
2017     Belgian Health Care Knowledge Centre (KCE) Static automated external defibrillators for opportunistic use by bystanders
2021     NIHR Health Technology Assessment programme Statin Web-based Investigation of Side Effects Trial (Statin WISE Trial)
2006     Institute of Technology Assessment (ITA) Statins and their prognosed as well as real impact on hospital services in Austria
2006     National Institute for Health and Clinical Excellence (NICE) Statins for the prevention of cardiovascular events
2006     Quality Improvement Scotland (NHS QIS ) Statins for the prevention of cardiovascular events
2019     Belgian Health Care Knowledge Centre (KCE) Statins for the primary prevention of cardiovascular events
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Statins for the secondary prevention of cardiovascular diseases: an analysis of expected population health gains and cost-utility in Austria (Part II of the project 'Statins: A comparison between predicted and actual effects on population health in Austria)
2021     Swiss Federal Office of Public Health (FOPH) Statins in the primary prevention of cardiovascular events and mortality in Switzerland
2001     NIHR Health Technology Assessment programme Statistical assessment of the learning curves of health technologies
2014     HAYES, Inc. StatLock stabilization devices (Bard Access Systems) to reduce needlesticks and catheter-related bloodstream infection
2008     HAYES, Inc. StatLock stabilization devices (Bard Medical) to reduce needlesticks and catheter-related infection
2012     HAYES, Inc. Statscan critical imaging system (Lodox Systems (Pty) Ltd.) for evaluation of patients with trauma or injury
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Status quo mammography screening: evaluation results from organised programs
2013     HAYES, Inc. Stelara (ustekinumab; Janssen Biotech Inc.) for treatment of psoriatic arthritis
2010     HAYES, Inc. Stem cell implantation for spinal cord injury
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Stem cell therapy in heart failure prevention and progress
1997     Alberta Heritage Foundation for Medical Research (AHFMR) Stem cell transplantation
2001     The Swedish Council on Health Technology Assessment (SBU) Stem cell transplantation for metastasized kidney cancer - early assessment briefs (Alert)
2015     NIHR Health Technology Assessment programme Stem cell treatment for acute myocardial infarction
2002     Health Council of the Netherlands Gezondheidsraad (GR) Stem cells for tissue repair. Review, expert panel
2006     HAYES, Inc. Stent angioplasty for vertebral artery stenosis
2003     Institute for Clinical Effectiveness and Health Policy (IECS) Stent angioplasty in the treatment of carotid stenosis
2004     National Institute for Clinical Excellence (NICE) Stent placement for vena caval obstruction
2006     National Institute for Health and Clinical Excellence (NICE) Stent-graft placement in abdominal aortic aneurysm
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stent-grafting of the ascending aorta. Systematic review
2009     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stent-grafting of the ascending aorta. Systematic review - 1st update 2009
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Stent-grafts for abdominal aortic aneurysms (AAA). IPE-97/13 (Public report)
2006     Haute Autorite de sante (HAS) Stent-grafts in the treatment of thoracic aortic aneurysm and dissection
2003     National Institute for Clinical Excellence (NICE) Stentgraft placement in abdominal aortic aneurysm
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis
2010     Medical Advisory Secretariat (MAS) Stenting for peripheral disease of the lower extremities
1999     Hannover Medical School, Medizinische Hochschule Hannover (MHH) Stenting versus balloon angioplasty for coronary diseases - systematic review of medical efficacy and cost-effectiveness
2003     Hannover Medical School, Medizinische Hochschule Hannover (MHH) Stenting versus balloon angioplasty for coronary diseases - systematic review of medical efficacy and cost-effectiveness
2003     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Stenting versus balloon angioplasty for coronary heart diseases
2016     Adelaide Health Technology Assessment (AHTA) Stenting versus medical therapy for atherosclerotic renal artery stenosis
1999     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Stenting versus percutaneous transluminal coronary angioplasty (PTCA) for coronary disease - review of efficacy and efficiency
2003     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Stenting versus percutaneous transluminal coronary angioplasty (PTCA) for coronary disease - Update of the medical efficacy
2015     Andalusian Health Technology Assessment Area (AETSA) Stentoplasty effectiveness and safety for the treatment of osteoporotic vertebral fractures
1998     Wessex Institute for Health Research and Development (WIHRD) Stents for coronary artery disease (CAD)
1996     Scottish Health Purchasing Information Centre (SHPIC) Stents for coronary artery disease. Summary
2019     NIHR Health Technology Assessment programme Stepped approach to improving sexual function after gynaecological cancer: the SAFFRON feasibility RCT
2008     NIHR Health Technology Assessment programme Stepped treatment of older adults on laxatives. The STOOL trial
2017     NIHR Public Health Research (PHR) programme Steps Towards Alcohol Misuse Prevention Programme (STAMPP): a school- and community-based cluster randomised controlled trial
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Stepwise approach for the prescription of opiates for non-cancer pain: a review of clinical evidence and guidelines
1996     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Stereostatic surgery
2022     Health Technology Wales (HTW) Stereotactic ablative radiotherapy (SABR) for the treatment of renal cell carcinoma
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Stereotactic ablative radiotherapy for the treatment of oligometastatic cancer: a clinical review as part of a health technology assessment v1.0
2016     HAYES, Inc. Stereotactic body radiation therapy with CyberKnife Robotic Radiosurgery System (Accuray Inc.) boost treatment in primary localized prostate cancer
2016     HAYES, Inc. Stereotactic body radiation therapy with CyberKnife Robotic Radiosurgery System (Accuray Inc.) monotherapy of primary localized prostate cancer
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Stereotactic breast biopsy
2004     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Stereotactic breast biopsy - study results
2000     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Stereotactic neurosurgical robot
1998     VA Technology Assessment Program (VATAP) Stereotactic pallidotomy for treatment of Parkinson's disease
1995     University HealthSystem Consortium (UHC) Stereotactic radiosurgery
1995     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Stereotactic radiosurgery - primary research
1992     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Stereotactic radiosurgery - summary
1993     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Stereotactic radiosurgery (SR)
2002     HAYES, Inc. Stereotactic radiosurgery for arteriovenous malformations and intracranial tumors
2009     HAYES, Inc. Stereotactic radiosurgery for arteriovenous malformations and intracranial tumors
2001     Wessex Institute for Health Research and Development (WIHRD) Stereotactic radiosurgery for brain tumours and arteriovenous malformations
1997     VA Technology Assessment Program (VATAP) Stereotactic radiosurgery for metastases to the brain: a systematic review of published studies of effectiveness
2002     HAYES, Inc. Stereotactic radiosurgery for trigeminal neuralgia and movement disorders
2004     National Institute for Clinical Excellence (NICE) Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife
2003     National Institute for Clinical Excellence (NICE) Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife
2002     The Swedish Council on Health Technology Assessment (SBU) Stereotactic radiosurgery in treating arteriovenous malformations of the brain - early assessment briefs (Alert)
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Stereotactic radiosurgery: an update
1997     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Stereotactic radiosurgery: indications and Spanish situation. IPE-97/12 (Public report)
1998     Alberta Heritage Foundation for Medical Research (AHFMR) Stereotactic radiosurgery: options for Albertans
2007     VA Technology Assessment Program (VATAP) Stereotactic radiosurgery: update
2022     NIHR Health Technology Assessment programme StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): A randomised, double-masked, sham- controlled, clinical trial comparing low-voltage X-ray irradiation with as needed ranibizumab, to as needed ranibizumab monotherapy
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Stereotactic radiotherapy, proton therapy and irreversible electroporation for the treatment of localised prostate cancer
1994     Health Council of the Netherlands Gezondheidsraad (GR) Stereotactic radiotherapy: the gamma knife and other techniques
2011     HAYES, Inc. Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for catheter ablation of atrial fibrillation and other arrhythmias
2013     HAYES, Inc. Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for catheter ablation of atrial fibrillation and other arrhythmias
2012     HAYES, Inc. Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for percutaneous coronary intervention in coronary artery disease
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterile pre-filled saline syringes for acute care patients: a review of clinical evidence, cost-effectiveness, evidence-based guidelines, and safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization equipment and requirements for endoscopy equipment: a review of the clinical evidence and guidelines
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of foot care instruments: a review of the guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Sternal talon for cardiac surgery patients: a review of the clinical effectiveness and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) STG 320 for allergic rhinitis
2013     HAYES, Inc. Stickler syndrome (arthro-ophthalmopathy)
1999     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Stillbirths within the framework of midwifery pilot projects in Quebec
2008     HAYES, Inc. Stimulants for attention-deficit hyperactivity disorder (ADHD) in adults
2009     HAYES, Inc. Stimulants for Attention-Deficit/Hyperactivity Disorder (ADHD) in children
2006     National Institute for Health and Clinical Excellence (NICE) Stimulated graciloplasty for faecal incontinence
2000     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Stimulation in Parkinson's disease - systematic review, expert panel
2013     Institute of Health Economics (IHE) Stingray catheter and guidewire for recanalization of coronary chronic total occlusions: a rapid evidence assessment
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Stiripentol (Diacomit — Biocodex SA) indication: severe myoclonic epilepsy in infancy (Dravet syndrome)
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Stiripentol (Diacomit®) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy
2000     The Swedish Council on Health Technology Assessment (SBU) Stomach pain - evidence-based methods in the diagnosis and treatment of dyspepsia